HR Positive Breast Cancer Cope
Breast cancer is a serious threat to women ‘ s health, of which HR positive breast cancer is the more common type. Knowledge about positive breast cancer is important for patients, families and the general public, contributing to early detection, active treatment and better rehabilitation. ii. What is a positive breast cancer HR Positive breast cancer is a female hormone receptor (ER) and/or a pregnant hormone receptor (PR) expressed as positive breast cancer. Estrogens and gestation hormones play an important role in the growth and development of the breast, which means that the growth of tumour cells may be influenced by the levels of estrogens and gestation hormones in the body, when the receptors of these hormones are expressed positively on breast cancer cells. This type of breast cancer accounts for about 70% of all breast cancers. Epidemiological factors (i) Hormonal-related factors. Long-term exposure of women to high levels of estrogen is one of the major morbidity factors. The early onset of menstruation (less than 12 years of age) and the late age of menstruation (more than 55 years of age) have led to longer estrogen effects in women. In addition, the long-term use of estrogen-containing drugs or health-care products, as well as the failure to give birth, late childbirth or breast-feeding after childbirth, may increase the cumulative exposure to estrogen in the body, thus increasing the risk of HIV positive breast cancer. (ii) Lifestyle factors. Poor living habits, such as chronic high consumption of alcohol, obesity and lack of physical activity, are associated with positive breast cancer. Alcohol affects liver metabolism to estrogen and increases estrogen levels in the body. Fat cells in obese women produce estrogen, increasing the total estrogen. Long-term sit-ins and a lack of sports are also detrimental to maintaining the balance of the body’s endocrine. iv. Clinical performance (i) breast swelling, most commonly in the breast, mostly pain-free. The swollen surface is hard, the boundary may be less clear and activity varies depending on the tumour. Early swelling is small and may not be easily detectable and increases as the condition evolves. (ii) Leaching of nipples. Some of the patients are exposed to a graft spill, which may be of a hemogenic nature, plasma or water sample. The fact that the nipple spill may be spontaneous or may occur when the nipple is squeezed requires attention. (iii) Breast skin changes when tumours violate breast dyslexia, which constricts the dysentery and causes a “dimple intoxication” in the breast skin. If cancer cells block lymph tubes, they can cause breast skin oedema, resulting in a change in the “Orange skin”. (iv) nipple and tizziness Changes The nipples may retort, tilt, and if the tumor is found below the nipples, they can be held to the point where the nipples are dimmed. There may also be changes in the wet rash pattern, accompanied by itching, decrum etc. Diagnosis (i) Medical examination The doctor, through contact with the breasts and armpits, is aware of the size, mass, boundary, activity and lymphoma lymphoma ligature of the swollen mass, as well as of the breast, tizziness and breast skin abnormalities. 1. Breast ultrasound: can observe the shape, size, internal echoes of the swelling, whether physical or cystic, and can also see if the lymphoma is swollen and has the advantage of being inconvenient and convenient. Breast molybdenum target: Sensitivity to the discovery of small calcified stoves contributes to early diagnosis, especially for older women. 3. Magnetic resonance of the mammography (MRI): high resolution, more accurate tumour range, relationship to the surrounding tissue, high diagnostic value for multi-cropping, multi-centre pathologies, but high cost and long duration of examination. (iii) Pathological examinations to obtain tissues and to perform pathological examinations by means of a perforation or surgical excise. In addition to routine pathological observation of cell forms, the expression estrogen receptor (ER) and pregnancy hormone receptor (PR) etc. must be tested to determine whether it is HR positive breast cancer. Treatment (i) Endocrinology treatment is one of the most important treatments for positive breast cancer in HR. The growth of tumour cells is inhibited by drug inhibition of estrogen generation or the disruption of the association of estrogen and receptor. Among the most common drugs are Moxiphine, aromatic enzyme inhibitors, etc. For pre-menopausal women, he is a common drug; after menopausal women use more aromatic enzymes. (ii) Surgical treatments, such as breast cancer improvement root therapy, breast-milk surgery, etc., are suitable for surgery, depending on the size and location of the tumor. The purpose of the operation is to remove the tumour tissue to the extent possible, taking into account the appearance and upper limb function of the patient. (iii) chemotherapy may be used as an auxiliary treatment for patients with some of the more serious cases with a high risk of relapse transfer. The size of the tumor can be reduced before the surgery (new assisted chemotherapy) and the risk of relapse after the operation (auxiliary chemotherapy). (iv) Treatment may reduce the rate of local recurrence when there is a high risk of local recurrence, e.g., after breast-feeding or greater transfer of lymph nodes in the armpit. The prognosis for post-natal and post-rehabilitation HR positive breast cancer is relatively good, especially for patients who have been detected at an early stage and who have undergone regular treatment. In the process of rehabilitation, care is taken to exercise upper limbs and to maintain a good mindset and living habits. At the same time, regular follow-up visits, including medical examinations, visual checks, etc., are required in order to detect possible recurrences and transfers in a timely manner. In sum, HR positive breast cancer has its unique biological characteristics and methods of treatment, and raising awareness of it helps to better combat the disease.
